期刊文献+

TNF-α启动子-308位点多态性与重症肌无力的相关性 被引量:3

Association of the tumor necrosis factor-alpha-308 polymorphism with myasthenia gravis
下载PDF
导出
摘要 目的探讨肿瘤坏死因子(tumor necrosis factor,TNF)-α启动子区域-308位点基因多态性与重症肌无力(myasthenia gravis,MG)的相关性。方法采用聚合酶链反应及基因测序技术检测289例MG患者与304名健康对照者TNF-α-308位点的基因型及等位基因分布频率,进一步根据MG患者性别、年龄、临床分型等进行分组,比较各组间TNF-α-308位点基因型及等位基因分布频率的差异。结果 MG患者及健康对照组均未发现A/A基因型;MG患者TNF-α启动子-308位点G/A基因型和等位基因A出现的频率与健康对照组比较差异无统计学意义(P>0.05)。相同性别间比较,男性MG组G/A基因型(P=0.025,OR=2.673,95%CI:1.105~6.467)及A等位基因(P=0.029,OR=2.533,95%CI:1.071~5.991)出现的频率高于健康对照组;发病年龄<40岁的MG组,全身型G/A基因型(P=0.004,OR=4.760,95%CI:1.533~14.778)及A等位基因(P=0.005,OR=4.298,95%CI:1.450~12.740)出现的频率高于眼肌型。结论 TNF-α-308位点多态性与中国北方地区男性MG患者及早发全身型MG患者发病相关。 Objective To analyze the relationship between the single nucleotide polymorphisms (SNP) of the tumor necrosis factor-alpha -308 (TNF-α-308) and the myasthenia gravis (MG) in Han population from North of China. Methods TNF-α-308 gene polymorphism in 289 patients with MG and 304 healthy people was detected by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing technology. Sub-groups were divided according to gender, age, and clinical classification. The genotypes of the different groups were statistically analyzed. Results In the MG group and control group, A/A genotype was not found, while TNF-α-308 G/G and G/A genotype were detected. There was no significant difference in the frequencies of TNF-α-308 G/A genotype and A allele between the MG group and the control group (P〉0.05). The frequencies of TNF-α-308 G/A genotype and A allele were higher in the MG group [ (P =0. 025, OR=2. 673, 95%CI: 1. 105-6. 467), (P=0. 029, OR=2. 533, 95%CI: 1. 071-5. 991), respectively] than in the control group in the male population. In the patients younger than 40, the frequencies of TNF-a-308 G/A genotype and A allele were increased in the anti-oMG[ (P=0. 004, OR=4. 760, 95%CI: 1. 533-14. 778), (P=0. 005, OR=4. 298, 95%CI: 1. 450-12. 740), respectively] compared with oMG patients. A allele were not found in the late-onset anti-oMG patients. Conclusions TNF-α-308 G/A genotype and A allele may be associated with the early-onset anti-oMG patients and male MG patients from North of China.
出处 《中国神经免疫学和神经病学杂志》 CAS 北大核心 2012年第4期292-295,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 国家自然科学基金资助项目(30700242) 北京市科技新星资助项目(A类 2008A87)
关键词 重症肌无力 肿瘤坏死因子-α-308位点 基因多态性 myasthenia gravis tumor necrosis factor alpha -308 single nucleotide polymorphisms
  • 相关文献

参考文献4

二级参考文献37

  • 1Oiraud M, Beaurain G, Yamamoto AM, et al. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti titin antibodies[J]. Neurology, 2001, 57 (9) 1555- 1560.
  • 2Giraud M, Taubert R, Vandiedonck C, et al. An IRF8 binding promoter variant and AIRE control CHRNA1 pro- miscuous expression in thymus[J]. Nature, 2007,448 ( 7156) : 934-937.
  • 3Kyewski B, Klein L. A central role for central tolerance[J]. Annu Rev Immunol,2006,24:571- 606.
  • 4Giraud M, Eymard B, Tranchant C, et al. Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis[J]. Genes Immun,2004,5(1) : 80- 83.
  • 5Vandiedonck C, Capdevielle C,Giraud M, et al. Association of the PTPN22 * R620W polymorphism with autoimmune myasthenia gravis[J]. Ann Neurol, 2006, 59(2):404-407.
  • 6Greve B, Hoffmann P, Illes Z, et al. The autoimmunity related polymorphism PTPN22 1858C/T is associated with anti titin antibody-positive myasthenia gravis[J]. Hum Immunol, 2009, 70(7): 540- 542.
  • 7Chuang WY, Strobel P, Betharazem D, et al. The PTPN22 (gain-of-funetion)+1858T(+) genotypes correlate with low IL-2 expressi.on in thymomas and predispose to myasthenia gravis[J]. Genes Immun, 2009,10(8) :667-672.
  • 8van der Pol WL, Jansen MD, Kuks JB, et al. Association of the Fc gamma receptor IIA-R/R13] genotype with myasthenia gravis in Dutch patients[J]. J Neuroimmunol, 2003, 144(1- 2): 143-147.
  • 9Wang XB, Kakoulidou M, Qiu Q, et al. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis[J]. Genes Immun, 2002, 3 (1) : 46- 49.
  • 10Heckmann JM, Uwimpuhwe H, Ballo R, et al. A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis[J]. Genes Immun, 2010,11(1) : 1-10.

共引文献21

同被引文献67

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部